Literature DB >> 6686556

Therapy of advanced breast cancer; a review.

E Engelsman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6686556     DOI： 10.1016/0277-5379(83)90166-9

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  3 in total

Review 1.  Hormone resistance, invasiveness, and metastatic potential in breast cancer.

Authors:  R Clarke; E W Thompson; F Leonessa; J Lippman; M McGarvey; T L Frandsen; N Brünner
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

2.  CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study.

Authors:  K Kolarić; A Roth; D Vukas; J Cervek
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Urinary androgens and tumor estrogen receptor as predictors of ovariectomy response and of survival in advanced breast cancer.

Authors:  S Oriana; G Secreto; G Di Fronzo; A Torri
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.